Cargando…
FGF13 Is a Novel Regulator of NF-κB and Potentiates Pathological Cardiac Hypertrophy
Autores principales: | Sun, Jia, Niu, Chao, Ye, Weijian, An, Ning, Chen, Gen, Huang, Xiaozhong, Wang, Jianan, Chen, Xixi, Shen, Yingjie, Huang, Shuai, Wang, Ying, Wang, Xu, Wang, Yang, Jin, Litai, Cong, Weitao, L, Xiaokun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291463/ https://www.ncbi.nlm.nih.gov/pubmed/37378312 http://dx.doi.org/10.1016/j.isci.2023.106975 |
Ejemplares similares
-
FGF13 Is a Novel Regulator of NF-κB and Potentiates Pathological Cardiac Hypertrophy
por: Sun, Jia, et al.
Publicado: (2020) -
aFGF alleviates diabetic endothelial dysfunction by decreasing oxidative stress via Wnt/β-catenin-mediated upregulation of HXK2
por: Sun, Jia, et al.
Publicado: (2020) -
bFGF alleviates diabetes-associated endothelial impairment by downregulating inflammation via S-nitrosylation pathway
por: Chen, Gen, et al.
Publicado: (2021) -
Resveratrol Promotes Diabetic Wound Healing via SIRT1-FOXO1-c-Myc Signaling Pathway-Mediated Angiogenesis
por: Huang, Xiaozhong, et al.
Publicado: (2019) -
FGF6 promotes cardiac repair after myocardial infarction by inhibiting the Hippo pathway
por: Hu, Zhicheng, et al.
Publicado: (2022)